About Imatinib for system suitability
Imatinib for system suitabilityEuropePharmacopoeia (EP) Reference StandardSynonym: 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate, 4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate, CGP 57148, Genfatinib, Glivec, Imatinib mesylate, Imatinib methanesulfonate, STI-571CAS Number220127-57-1Empirical Formula (Hill Notation)C29H31N7O CH4O3SMolecular Weight589.71PropertiesRelated CategoriesAnalytical Standards,Analytical/Chromatography,EP Standards,EP Standards I - K,Pharmacopeia & Metrological Institutes Standards
FAQs of Imatinib for system suitability:
Q: What is the molecular formula of Imatinib?
A: The molecular formula of Imatinib is C29H31N7O.
Q: What is the purity level of Imatinib?
A: Imatinib has a purity of 99%.
Q: What is the molecular weight of Imatinib?
A: The molecular weight of Imatinib is 493.6 grams (g).
Q: What types of cancer can Imatinib treat?
A: Imatinib is used to treat acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases.
Q: What is the melting point of Imatinib?
A: The melting point of Imatinib is 226.